Connect with us

Hi, what are you looking for?

News

Filipino Jesus Actor Gets Nabbed For Selling Drugs

Which part of the Bible says it’s okay to do drugs?

Image via CDN

I must have missed the part of the Bible where the big man upstairs tells us it’s okay to do drugs, but clearly this man didn’t.

In Cebu City, Philippines – 24-year-old Mark Anthony Jakosalem was arrested for possession of alleged illegal drugs on Easter Sunday, 21 April 2019.

This alone wouldn’t be too unusual. However, this particular man enjoyed playing the role of Jesus on stage plays during Easter Sunday. He did so for six years straight (from 2011 to 2017). Talk about dedication to a role!

Personnel from the Drug Enforcement Unit of of the Abellana Police Station (Station 2) arrested Jakosalem on about 11pm on Sunday. He was caught with 1,200 Philippine Peso worth of drugs, which amounts to about 18 quid worth.

Image via PhilNews

Jakosalem is currently detained at Station 2. He definitely has a lot to think about, especially considering Filipino President Duterte’s vow to ‘slaughter’ anyone involved in illegal use. The man should have just stuck with acting as Jesus, really.

Police Major Eduard Sanchez, head of the operation, asserted that despite the small quantity Jakosalem was well known for selling drugs in his village and was capable of selling up to 15 sachets of illegal drugs a day.

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Sport

The 2026 FIFA World Cup generates billions of dollars but who profits most from the tournament.

Home

Owning a house in the UK used to be a life goal for many young people, but now it has become a growing source...

Sport

Here's a look at the tracks powering the 2026 American League All-Stars and the stories behind the music they bring to the plate.

POV

A concise look at how political language in the 2026 counterterrorism strategy reshapes who can be labeled a “terrorist.”

Copyright © 2025 Trill Voices, Inc